Bilcare Ltd Board Meeting on Nov 3 to Approve Q2 FY27 Results

Bilcare Limited has announced that its Board of Directors will convene on November 3, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. The company also confirmed that the trading window for dealing in its securities will remain closed from October 1, 2026, until 48 hours after the declaration of these financial results, in compliance with SEBI regulations.